Vertex Pharmaceuticals Incorporated (0QZU.L) LSE

395.35

-1.9399(-0.49%)

Updated at September 08 02:58PM

Currency In USD

Valuation

Market Cap103.7B
Enterprise Value100.88B
P/E Ratio27.95
PEG Ratio0.06
Price/Sales Ratio8.89
Price/Book Ratio5.92
Enterprise/Revenue8.47
Enterprise/EBITDA20.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.32
Operating Margin0.34

Management Effectiveness

Return On Assets0.15
Return On Equity0.22

Income Statement

Revenue11.02B
Revenue/Share44.48
Gross Profit9.49B
EBITDA486.3M
Net Income-535.6M
Diluted EPS-2.08

Balance Sheet

Total Cash6.38B
Total Cash/Share30.36
Total Debt1.53B
Total Debt/Equity0.09
Current Ratio2.52
Book Value Per Share66.91

Price History

52-Week Change-15.67
52-Week High446.29
52-Week Low290.87
Moving Average 50 Days424.38
Moving Average 200 Days373.25

Statistics

Average Volume2,907
Shares Outstanding256.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A